Core Laboratories Inc [NYSE: CLB] traded at a low on 2025-07-03, posting a -0.85 loss after which it closed the day’ session at $12.79.
The results of the trading session contributed to over 337429 shares changing hands. Over the past one week, the price volatility of Core Laboratories Inc stands at 5.20% while the volatility over the past one month is 4.70%.
The market cap for CLB stock reached $599.63 million, with 46.70 million shares outstanding and 46.36 million shares in the current float. Compared to the average trading volume of 574.87K shares, CLB reached a trading volume of 337429 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Core Laboratories Inc [CLB]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLB shares is $14.60 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLB stock is a recommendation set at 3.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Core Laboratories Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 12, 2025. While these analysts kept the previous recommendation, Citigroup dropped their target price from $22 to $21. The new note on the price target was released on June 30, 2023, representing the official price target for Core Laboratories Inc stock. Previously, the target price had yet another raise to $21.50, while BofA Securities analysts kept a Underperform rating on CLB stock.
The Price to Book ratio for the last quarter was 2.36, with the Price to Cash per share for the same quarter was set at 0.47. Price to Free Cash Flow for CLB in the course of the last twelve months was 13.83 with Quick ratio for the last quarter at 1.64.
How has CLB stock performed recently?
Core Laboratories Inc [CLB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.39. With this latest performance, CLB shares gained by 11.51% in over the last four-week period, additionally sinking by -25.07% over the last 6 months – not to mention a drop of -26.11% in the past year of trading.
Core Laboratories Inc [CLB]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Core Laboratories Inc [CLB] shares currently have an operating margin of 8.87% and a Gross Margin at 16.91%. Core Laboratories Inc’s Net Margin is presently recorded at 5.41%.
Return on Equity for this stock inclined to 4.75%, with Return on Assets sitting at 4.75%.
Earnings analysis for Core Laboratories Inc [CLB]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Core Laboratories Inc go to 3.35%.
Insider trade positions for Core Laboratories Inc [CLB]
There are presently around $117.55%, or 118.75% of CLB stock, in the hands of institutional investors. The top three institutional holders of CLB stocks are: ARIEL INVESTMENTS, LLC with ownership of 10.29 million shares, which is approximately 21.9415%. BLACKROCK INC., holding 7.8 million shares of the stock with an approximate value of $$158.22 million in CLB stocks shares; and BLACKROCK INC., currently with $$112.23 million in CLB stock with ownership which is approximately 11.7921%.
